Atherosclerotic vascular disease: management of angina in the office setting.
A discussion of primary care issues related to the management of angina in the office setting is warranted because of recent developments. These developments include new pharmacotherapies, recent insights into the pathophysiology of angina, and increased recognition of the role of the diseased endothelium in sequelae of coronary artery disease.
Kuritzky
L
L
University of Florida, Gainesville,USA. lkuritzky@aol.com Florida.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D005996:Nitroglycerin / Q000627:therapeutic use; D011379:Prognosis; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D014665:Vasodilator Agents; D005996:Nitroglycerin